Does Abciximab Promote Coronary Artery Remodeling in Patients With Kawasaki Disease?
Standard therapy, consisting of intravenous immunoglobulin and aspirin, reduces, but does not eliminate, coronary artery aneurysms (CAAs) in patients with Kawasaki disease. Large CAAs can persist or undergo varying degrees…